← FDA Drug Approvals (Drugs@FDA)

POMALYST

NDA · New Drug Application · Sponsor: BRISTOL · Approved 2013-02-08

Drug application

FDA Application #

NDA204026

Application type

New Drug Application

Brand name

POMALYST

Generic name

POMALIDOMIDE

Active ingredients

POMALIDOMIDE

Dosage form

CAPSULE

Route

ORAL

Marketing status

Prescription

Sponsor

BRISTOL

Manufacturer

Celgene Corporation

First approval

2013-02-08

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown